Optic nerve regeneration

Optic nerve regeneration is a complex biological process involving the regrowth of Retinal Ganglion Cell (RGC) axons to restore functional connections between the eye and the brain after injury or disease. In adult mammals, the optic nerve—part of the central nervous system (CNS)—exhibits a failure to spontaneously regenerate due to an intrinsically low growth state of mature neurons and an inhibitory microenvironment containing myelin-associated proteins and glial scars. Therapeutic strategies to promote regeneration focus on manipulating signaling pathways, such as inhibiting PTEN or SOCS3 to activate mTOR, or using neurotrophic factors like Ciliary Neurotrophic Factor (CNTF) to transition RGCs into an active growth state. Research also targets mitochondrial dynamics and the Rho/ROCK pathway to overcome physical and biochemical barriers to axonal extension. Successful regeneration is characterized not only by axonal outgrowth but also by proper guidance to subcortical visual targets and subsequent myelination to facilitate functional vision recovery.

Other names

Axonal regeneration of retinal ganglion cellsRGC regenerationVisual system repairOptic nerve regrowthRetinal Ganglion Cell (RGC) axon regeneration

Drugs targeting this process generally work by: 1) Activating intrinsic growth pathways (e.g., PI3K/AKT/mTOR activation via PTEN inhibition); 2) Neutralizing extrinsic inhibitors (e.g., Nogo receptor antagonism); 3) Modulating the cytoskeleton and mitochondrial transport to fuel axonal extension (e.g., ROCK inhibition or mitochondrial fusion promoters); or 4) Delivering neurotrophic support to prevent RGC apoptosis.